Eli Lilly and Company Files Complaint with U.S. International Trade Commission Over Tirzepatide Products

Summary

Eli Lilly and Company has filed a complaint with the U.S. International Trade Commission alleging that certain products containing tirzepatide and products purporting to contain tirzepatide infringe on its trademark and engage in false advertising practices, threatening to harm the U.S. industry.